NHS watchdog blocks AstraZeneca breast cancer drug - Financial Times
- NHS watchdog blocks AstraZeneca breast cancer drug Financial Times
- Terminally-ill breast cancer sufferers denied life-extending drug The Telegraph
- NICE disappointed companies unwilling to offer fair price to make Enhertu available for advanced breast cancer NICE
- Life-extending drug for incurable breast cancer WILL NOT be made available on the NHS amid row over cost Daily Mail
- After tense standoff, AstraZeneca and Daiichi's Enhertu turned away by NICE on pricing grounds FiercePharma